WO2008003185A1 - Verwendung von extrakten oder extraktivstoffen aus guajacum arten, wobei diese extrakte oder diese extraktivstoffe eine phosphodiesterase- 4 -hemmung bewirken, und verfahren zu deren gewinnung - Google Patents
Verwendung von extrakten oder extraktivstoffen aus guajacum arten, wobei diese extrakte oder diese extraktivstoffe eine phosphodiesterase- 4 -hemmung bewirken, und verfahren zu deren gewinnung Download PDFInfo
- Publication number
- WO2008003185A1 WO2008003185A1 PCT/CH2007/000325 CH2007000325W WO2008003185A1 WO 2008003185 A1 WO2008003185 A1 WO 2008003185A1 CH 2007000325 W CH2007000325 W CH 2007000325W WO 2008003185 A1 WO2008003185 A1 WO 2008003185A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- guajacum
- disease
- extract
- extracts
- alcohol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020087030746A KR101170209B1 (ko) | 2006-07-05 | 2007-07-04 | 포스포디에스터라제-4 억제에 효과가 있는 구아야쿰 종으로부터의 추출물 또는 추출 물질의 용도 및 이의 제조 방법 |
US12/227,596 US7914827B2 (en) | 2006-07-05 | 2007-07-04 | Use of extracts or extractants of the guajacum types, said extracts or extractants bringing about phosphodiesterase-4 inhibition and method for producing the same |
JP2009516852A JP2009541366A (ja) | 2006-07-05 | 2007-07-04 | ホスホジエステラーゼ−4の阻害をもたらす、ユソウボク属植物の抽出物または抽出物質の使用、ならびにその調製方法 |
EP07763932A EP2035025A1 (de) | 2006-07-05 | 2007-07-04 | Verwendung von extrakten oder extraktivstoffen aus guajacum arten, wobei diese extrakte oder diese extraktivstoffe eine phosphodiesterase- 4 -hemmung bewirken, und verfahren zu deren gewinnung |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1076/06 | 2006-07-05 | ||
CH10762006 | 2006-07-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008003185A1 true WO2008003185A1 (de) | 2008-01-10 |
Family
ID=37847140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CH2007/000325 WO2008003185A1 (de) | 2006-07-05 | 2007-07-04 | Verwendung von extrakten oder extraktivstoffen aus guajacum arten, wobei diese extrakte oder diese extraktivstoffe eine phosphodiesterase- 4 -hemmung bewirken, und verfahren zu deren gewinnung |
Country Status (5)
Country | Link |
---|---|
US (1) | US7914827B2 (de) |
EP (1) | EP2035025A1 (de) |
JP (1) | JP2009541366A (de) |
KR (1) | KR101170209B1 (de) |
WO (1) | WO2008003185A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102499738B1 (ko) * | 2009-08-26 | 2023-02-13 | 마리 케이 인코포레이티드 | 식물 추출물을 포함하는 국소 피부 케어 제형 |
CN111321601B (zh) * | 2020-03-16 | 2021-10-12 | 南通大学 | 一种防紫外竹纤维面料及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4774229A (en) * | 1982-04-05 | 1988-09-27 | Chemex Pharmaceuticals, Inc. | Modification of plant extracts from zygophyllaceae and pharmaceutical use therefor |
DE10131036A1 (de) * | 2001-06-29 | 2003-06-05 | Johann Teubner | Elexier gegen HIV |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6393722A (ja) * | 1986-09-22 | 1988-04-25 | ブラディミール・バッドマージュ | 医薬の処方 |
JPH07165597A (ja) * | 1993-12-07 | 1995-06-27 | Souyaku Gijutsu Kenkyusho:Kk | ハマビシ科植物の有機抽出物を含有する抗ウイルス剤 |
JPH09255551A (ja) * | 1996-03-28 | 1997-09-30 | Shiseido Co Ltd | 皮膚外用剤 |
US20030055007A1 (en) * | 2001-08-02 | 2003-03-20 | Kazuo Sakuma | Antimicrobial agents |
-
2007
- 2007-07-04 US US12/227,596 patent/US7914827B2/en not_active Expired - Fee Related
- 2007-07-04 KR KR1020087030746A patent/KR101170209B1/ko not_active IP Right Cessation
- 2007-07-04 JP JP2009516852A patent/JP2009541366A/ja active Pending
- 2007-07-04 EP EP07763932A patent/EP2035025A1/de not_active Withdrawn
- 2007-07-04 WO PCT/CH2007/000325 patent/WO2008003185A1/de active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4774229A (en) * | 1982-04-05 | 1988-09-27 | Chemex Pharmaceuticals, Inc. | Modification of plant extracts from zygophyllaceae and pharmaceutical use therefor |
DE10131036A1 (de) * | 2001-06-29 | 2003-06-05 | Johann Teubner | Elexier gegen HIV |
Non-Patent Citations (6)
Title |
---|
ADVANCES IN THERAPY, vol. 15, no. 6, November 1998 (1998-11-01), pages 362 - 371, ISSN: 0741-238X * |
ADVANCES IN THERAPY, vol. 17, no. 4, July 2000 (2000-07-01), pages 197 - 203, ISSN: 0741-238X * |
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; July 2000 (2000-07-01), RAU EDELTRAUD: "Treatment of acute tonsillitis with a fixed-combination herbal preparation", XP002425881, Database accession no. PREV200000500274 * |
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; November 1998 (1998-11-01), WIESENAUER M: "Comparison of solid and liquid forms of homeopathic remedies for tonsilitis", XP002425880, Database accession no. PREV199900142233 * |
DATABASE EMBASE [online] ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; 1994, DUWIEJUA M ET AL: "Anti-inflammatory activity of Polygonum bistorta, Guaiacum officinale and Hamamelis virginiana in rats", XP002425879, Database accession no. EMB-1994122031 * |
JOURNAL OF PHARMACY AND PHARMACOLOGY 1994 UNITED KINGDOM, vol. 46, no. 4, 1994, pages 286 - 290, ISSN: 0022-3573 * |
Also Published As
Publication number | Publication date |
---|---|
US20090142423A1 (en) | 2009-06-04 |
JP2009541366A (ja) | 2009-11-26 |
KR101170209B1 (ko) | 2012-07-31 |
US7914827B2 (en) | 2011-03-29 |
KR20090026287A (ko) | 2009-03-12 |
EP2035025A1 (de) | 2009-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0599307B1 (de) | Johanniskraut-Trockenextrakt, Verfahren zu seiner Herstellung und seine Verwendung | |
DD277210A5 (de) | Therapeutische zusammensetzungen gegen psoriasis | |
DE102014202318B4 (de) | Verbessertes Verfahren zur Herstellung von Ginkgoextrakten | |
EP1852105B1 (de) | Verfahren zur Herstellung einer triterpensäurehaltigen wässrigen Lösung, triterpensäurehaltige wässrige Lösung und deren Verwendung | |
DE10220149B4 (de) | Pharmazeutische Antidepressions-Zusammensetzung, die einen Polygala-Extrakt enthält | |
DE1467800A1 (de) | Verfahren zur Behandlung von insbesondere saponinhaltigen Pflanzen | |
EP2035025A1 (de) | Verwendung von extrakten oder extraktivstoffen aus guajacum arten, wobei diese extrakte oder diese extraktivstoffe eine phosphodiesterase- 4 -hemmung bewirken, und verfahren zu deren gewinnung | |
DE2347576A1 (de) | Anti-leukaemische substanz sowie verfahren zur herstellung einer solchen substanz | |
DE4028945A1 (de) | Kawa-kawa-extrakt, verfahren zu seiner herstellung und seine verwendung | |
EP0508330B1 (de) | Verfahren zur Herstellung von Extrakten aus Rhizoma Petasitidis mit Kohlendioxid | |
EP0285752B1 (de) | Kamillenöle mit hohem Gehalt an natürlichen Polyinen und Verfahren zu deren Herstellung | |
DE745383C (de) | Verfahren zur Gewinnung des antipernicioesen Wirkstoffs der Leber und eines neuen Aktivators dieses Wirkstoffs | |
DE4221537A1 (de) | Hamamelis-Trockenextrakt, Verfahren zu seiner Herstellung und seine Verwendung als Arzneimittel | |
WO1995002410A1 (de) | Verfahren zur herstellung flüssiger pflanzenauszüge | |
DE2905669C2 (de) | ||
DE2551962C3 (de) | Verwendung eines Extraktes aus verschiedenen Spezies von Helleborus | |
AT325783B (de) | Verfahren zum abtrennen des glykofrangulin-komplexes aus pflanzlichen rohstoffen, insbesondere aus der getrockneten rinde des faulbaumes | |
DE202023103881U1 (de) | Formulierung einer wundheilenden Kräutersalbe aus Strychnos Nux-Vomica L Samen | |
DE1695781C3 (de) | Psychotropes Arzneimittel | |
DE699903C (de) | Mit Wasser homogen verduennbare Praeparate aus Drogenauszuegen, aetherischen OElen u. dgl. | |
AT86428B (de) | Verfahren zur Herstellung zweier, therapeutisch wirksamer Stoffe aus Corpus luteum. | |
DE214805C (de) | ||
DE563258C (de) | Verfahren zur Darstellung wasserloeslicher, hormonartiger, wachstumfoerdernder Stoffe aus Thymusdruesen | |
DE4320889A1 (de) | Neue extrahierte Substanz mit Anti-HIV-Aktivität | |
DE3801959A1 (de) | Kamillenoele mit hohem gehalt an natuerlichen polyinen und verfahren zu deren herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07763932 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12227596 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007763932 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020087030746 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009516852 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 410/CHENP/2010 Country of ref document: IN |